POET Technologies Inc. (Nasdaq: POET) saw its shares decline sharply on Monday, closing down 14.2% at $13.70 in heavy Nasdaq trading, after the company announced the closing of a $400 million direct investment with MMCAP International Inc. SPC. The stock initially opened higher at $17.00 and touched an intraday high of $18.17 before reversing course, with volume surging to approximately 47.9 million shares. The TSX Venture-listed shares did not trade due to the Victoria Day holiday in Canada, with trading expected to resume on Tuesday.
Details of the Investment
Under the terms of the registered direct offering, POET sold 19,047,620 common shares and an equal number of warrants to MMCAP at a price of $21.00 per unit. The warrants carry an exercise price of $26.25 and a three-year term. Notably, the offering price exceeded POET's Nasdaq closing price of $20.57 on May 14, reflecting institutional confidence in the company's strategic direction. No placement agent was involved in the transaction.
The capital infusion comes at a critical juncture for POET, which is transitioning from development-stage to manufacturing-scale operations. The company plans to allocate the funds toward manufacturing infrastructure, strategic acquisitions, research and development, its light-source unit, and general working capital. CEO Suresh Venkatesan stated that the company is “expanding our capacity by roughly ten-fold,” citing the Lumilens order and other “high-volume opportunities.”
Market Reaction and Dilution Concerns
Despite the positive funding news, investors reacted negatively, likely due to dilution concerns. The issuance of new shares and warrants could dilute existing shareholders if the warrants are exercised. The stock's volatile session—from an opening of $17.00 to a high of $18.17 and then a low of $13.66—suggests market uncertainty about the near-term impact of the equity offering. Traders will be watching whether U.S. shares stabilize near the $21 financing level or continue to decline toward Monday's low.
Recent Financial Results and Lumilens Order
The funding follows a busy period for POET. Last week, the company reported first-quarter results, with revenue of $503,389, up from $166,760 in the prior-year period, but a net loss of $12.3 million, or $0.08 per share. The revenue was primarily derived from non-recurring engineering projects with a single customer, not from ongoing product sales.
More significantly, POET announced a $50 million initial order from Lumilens for its Electrical-Optical Interposer (EOI)-based engines. This order is the first step in a potential five-year agreement that could total over $500 million. The EOI platform integrates electronics and photonics at the wafer level, using light for data transmission, targeting 800G and 1.6T optical modules for AI data centers. Lumilens CEO Ankur Singla noted that “GPU interconnects” are becoming the primary bottleneck for scaling AI, driving investor interest in optical-networking stocks.
Management Changes and Customer Concentration Risk
On the management front, POET appointed Sandeep Kumar as chief operating officer. CFO Thomas Mika informed the board of his intention to retire later this year after a decade in the role.
Customer concentration remains a key risk. In late April, Marvell Semiconductor canceled all of POET's purchase orders related to Celestial AI, citing alleged confidentiality issues after acquiring Celestial. This development places greater emphasis on the Lumilens order and partnerships with Lite-On and Lessengers to demonstrate that POET's business is not overly reliant on a single customer.
Looking ahead, the company faces several challenges: the warrants could lead to further dilution, Lumilens revenue depends on successful development and qualification, and quarterly sales remain modest relative to the described opportunity. Any delays in qualification or failure to secure additional orders could keep the stock under pressure. Canadian investors will have their first opportunity to react when TSX Venture trading resumes on Tuesday.
